Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kinetochores | 42 | 2013 | 178 | 4.470 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 12 | 2017 | 192 | 2.710 |
Why?
|
Models, Biological | 47 | 2022 | 9467 | 2.330 |
Why?
|
Drug Discovery | 10 | 2023 | 1057 | 2.100 |
Why?
|
Chromosome Segregation | 18 | 2011 | 233 | 1.980 |
Why?
|
Software | 21 | 2024 | 4419 | 1.760 |
Why?
|
Apoptosis | 30 | 2023 | 9501 | 1.740 |
Why?
|
Signal Transduction | 62 | 2024 | 23376 | 1.720 |
Why?
|
Neoplasms | 35 | 2024 | 22072 | 1.710 |
Why?
|
Saccharomyces cerevisiae | 38 | 2013 | 2698 | 1.680 |
Why?
|
Melanoma | 14 | 2024 | 5697 | 1.650 |
Why?
|
Single-Cell Analysis | 19 | 2024 | 2380 | 1.570 |
Why?
|
Computational Biology | 24 | 2024 | 3505 | 1.560 |
Why?
|
Antineoplastic Agents | 26 | 2022 | 13630 | 1.540 |
Why?
|
Chromosomal Instability | 4 | 2017 | 177 | 1.500 |
Why?
|
Drug Resistance, Neoplasm | 19 | 2023 | 5253 | 1.490 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2023 | 2053 | 1.490 |
Why?
|
Protein Kinase Inhibitors | 23 | 2023 | 5643 | 1.460 |
Why?
|
Microscopy, Fluorescence | 9 | 2018 | 2651 | 1.390 |
Why?
|
Cell Line, Tumor | 55 | 2024 | 16939 | 1.310 |
Why?
|
MAP Kinase Signaling System | 9 | 2023 | 1484 | 1.250 |
Why?
|
Microtubules | 25 | 2011 | 1072 | 1.220 |
Why?
|
Saccharomyces cerevisiae Proteins | 25 | 2013 | 1854 | 1.210 |
Why?
|
Fungal Proteins | 15 | 2009 | 911 | 1.180 |
Why?
|
Chromosomes, Fungal | 10 | 2013 | 111 | 1.160 |
Why?
|
Data Mining | 3 | 2023 | 553 | 1.130 |
Why?
|
Protein Kinases | 14 | 2024 | 1612 | 1.090 |
Why?
|
Cell Cycle Proteins | 22 | 2020 | 3446 | 1.070 |
Why?
|
Tumor Microenvironment | 17 | 2024 | 3844 | 1.070 |
Why?
|
Small Molecule Libraries | 5 | 2019 | 734 | 1.010 |
Why?
|
Systems Biology | 11 | 2019 | 482 | 1.010 |
Why?
|
Proteins | 16 | 2024 | 6029 | 1.000 |
Why?
|
Cell Survival | 19 | 2022 | 5797 | 0.920 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2021 | 8515 | 0.900 |
Why?
|
High-Throughput Screening Assays | 7 | 2022 | 944 | 0.900 |
Why?
|
Natural Language Processing | 3 | 2023 | 1135 | 0.870 |
Why?
|
Mitosis | 12 | 2011 | 1191 | 0.840 |
Why?
|
Caspases | 9 | 2023 | 878 | 0.830 |
Why?
|
Respiratory Protective Devices | 2 | 2021 | 47 | 0.810 |
Why?
|
Caspase 8 | 6 | 2015 | 189 | 0.770 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 10827 | 0.770 |
Why?
|
Cell Proliferation | 13 | 2024 | 10446 | 0.770 |
Why?
|
Indoles | 4 | 2019 | 1829 | 0.770 |
Why?
|
Systems Theory | 3 | 2019 | 57 | 0.750 |
Why?
|
Microscopy | 9 | 2022 | 885 | 0.740 |
Why?
|
Ecosystem | 2 | 2022 | 485 | 0.720 |
Why?
|
Biophysics | 1 | 2021 | 380 | 0.710 |
Why?
|
Epidermal Growth Factor | 8 | 2022 | 695 | 0.700 |
Why?
|
Genes, cdc | 6 | 2005 | 115 | 0.690 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 198 | 0.690 |
Why?
|
DNA, Fungal | 10 | 2007 | 275 | 0.690 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.680 |
Why?
|
Humans | 199 | 2024 | 760621 | 0.680 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2020 | 717 | 0.680 |
Why?
|
HeLa Cells | 22 | 2017 | 3105 | 0.670 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 346 | 0.660 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2021 | 556 | 0.660 |
Why?
|
Naphthyridines | 2 | 2019 | 141 | 0.660 |
Why?
|
Hepatocytes | 6 | 2017 | 1229 | 0.650 |
Why?
|
Aneuploidy | 3 | 2014 | 551 | 0.630 |
Why?
|
Ubiquitin | 2 | 2022 | 838 | 0.620 |
Why?
|
Fluorescent Antibody Technique | 8 | 2024 | 2471 | 0.620 |
Why?
|
Protein Array Analysis | 3 | 2012 | 401 | 0.610 |
Why?
|
Heat-Shock Proteins | 9 | 2020 | 795 | 0.610 |
Why?
|
Computer Simulation | 20 | 2019 | 6218 | 0.610 |
Why?
|
Sulfonamides | 3 | 2017 | 1977 | 0.600 |
Why?
|
Synovial Fluid | 2 | 2018 | 395 | 0.600 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2919 | 0.590 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2020 | 3584 | 0.580 |
Why?
|
Trust | 1 | 2022 | 532 | 0.580 |
Why?
|
Programming Languages | 3 | 2013 | 128 | 0.570 |
Why?
|
Zearalenone | 1 | 2016 | 3 | 0.570 |
Why?
|
Computers | 1 | 2019 | 595 | 0.560 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2023 | 8950 | 0.560 |
Why?
|
Cell Physiological Phenomena | 4 | 2020 | 150 | 0.550 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2012 | 4357 | 0.550 |
Why?
|
Kinetics | 15 | 2022 | 6377 | 0.540 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2024 | 2864 | 0.540 |
Why?
|
Nuclear Proteins | 16 | 2011 | 5791 | 0.540 |
Why?
|
Drug Evaluation, Preclinical | 6 | 2018 | 1347 | 0.530 |
Why?
|
Animals | 79 | 2024 | 167963 | 0.530 |
Why?
|
Proteomics | 15 | 2024 | 3817 | 0.530 |
Why?
|
Staining and Labeling | 3 | 2022 | 1089 | 0.530 |
Why?
|
Models, Genetic | 2 | 2017 | 3442 | 0.530 |
Why?
|
Breast Neoplasms | 15 | 2024 | 21025 | 0.520 |
Why?
|
Centromere | 8 | 2007 | 213 | 0.520 |
Why?
|
Proto-Oncogene Proteins c-akt | 10 | 2024 | 2448 | 0.520 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2017 | 567 | 0.520 |
Why?
|
Cell Cycle | 7 | 2022 | 2934 | 0.510 |
Why?
|
Ovarian Neoplasms | 8 | 2022 | 4878 | 0.500 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11712 | 0.500 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2022 | 861 | 0.500 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5799 | 0.490 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8552 | 0.490 |
Why?
|
Synovial Membrane | 2 | 2022 | 524 | 0.480 |
Why?
|
Enzyme Activation | 6 | 2012 | 3602 | 0.480 |
Why?
|
Glioblastoma | 5 | 2024 | 3484 | 0.470 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 305 | 0.470 |
Why?
|
Proteome | 2 | 2019 | 1855 | 0.470 |
Why?
|
Cell Division | 6 | 2020 | 4463 | 0.470 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 2 | 2011 | 60 | 0.470 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 4 | 2023 | 642 | 0.470 |
Why?
|
Fibroblasts | 5 | 2020 | 4090 | 0.460 |
Why?
|
Pharmacogenetics | 2 | 2021 | 680 | 0.460 |
Why?
|
Microtubule-Associated Proteins | 5 | 2009 | 1077 | 0.460 |
Why?
|
Caspase 3 | 3 | 2011 | 731 | 0.460 |
Why?
|
Occupational Exposure | 2 | 2021 | 1809 | 0.450 |
Why?
|
Saccharomycetales | 3 | 2011 | 74 | 0.450 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2013 | 1135 | 0.450 |
Why?
|
Databases, Protein | 4 | 2021 | 388 | 0.440 |
Why?
|
User-Computer Interface | 3 | 2019 | 1403 | 0.440 |
Why?
|
Stochastic Processes | 2 | 2013 | 354 | 0.430 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2013 | 1613 | 0.430 |
Why?
|
DNA-Binding Proteins | 17 | 2012 | 9585 | 0.430 |
Why?
|
Cell Death | 4 | 2015 | 1672 | 0.430 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 935 | 0.420 |
Why?
|
Research Design | 3 | 2022 | 6180 | 0.420 |
Why?
|
Sequence Deletion | 1 | 2017 | 1493 | 0.410 |
Why?
|
Receptors, Growth Factor | 1 | 2013 | 326 | 0.410 |
Why?
|
Neurogenesis | 1 | 2019 | 856 | 0.410 |
Why?
|
Microchip Analytical Procedures | 3 | 2008 | 29 | 0.410 |
Why?
|
Cell Line | 17 | 2023 | 15620 | 0.410 |
Why?
|
Neural Stem Cells | 2 | 2019 | 884 | 0.400 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2021 | 656 | 0.400 |
Why?
|
Cell Biology | 1 | 2012 | 90 | 0.390 |
Why?
|
Calcium-Binding Proteins | 6 | 2011 | 1067 | 0.390 |
Why?
|
Clinical Trials as Topic | 4 | 2022 | 8056 | 0.380 |
Why?
|
Models, Theoretical | 5 | 2016 | 3562 | 0.380 |
Why?
|
Nerve Tissue Proteins | 3 | 2021 | 4407 | 0.380 |
Why?
|
Carrier Proteins | 6 | 2005 | 4938 | 0.380 |
Why?
|
Biochemistry | 2 | 2011 | 114 | 0.370 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1652 | 0.370 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.360 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 4 | 2023 | 616 | 0.360 |
Why?
|
Oncogenes | 4 | 2023 | 1220 | 0.360 |
Why?
|
Software Design | 1 | 2011 | 171 | 0.360 |
Why?
|
Drug Therapy, Combination | 4 | 2022 | 6498 | 0.360 |
Why?
|
Pharmacology, Clinical | 1 | 2010 | 22 | 0.360 |
Why?
|
Chromosomes | 4 | 2007 | 575 | 0.360 |
Why?
|
Mutation | 20 | 2023 | 29932 | 0.360 |
Why?
|
Database Management Systems | 2 | 2011 | 258 | 0.360 |
Why?
|
Adaptation, Physiological | 2 | 2020 | 1296 | 0.360 |
Why?
|
Biochemical Phenomena | 1 | 2010 | 58 | 0.360 |
Why?
|
Computer Graphics | 2 | 2022 | 341 | 0.350 |
Why?
|
Schizosaccharomyces | 2 | 2011 | 237 | 0.350 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1657 | 0.350 |
Why?
|
Pharmacological Phenomena | 1 | 2009 | 11 | 0.350 |
Why?
|
Plaque, Amyloid | 1 | 2014 | 758 | 0.350 |
Why?
|
Cluster Analysis | 8 | 2019 | 2698 | 0.340 |
Why?
|
Phosphorylation | 16 | 2021 | 8313 | 0.340 |
Why?
|
Drug Synergism | 4 | 2019 | 1754 | 0.340 |
Why?
|
Gene Expression Profiling | 13 | 2024 | 9411 | 0.340 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2009 | 17 | 0.330 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2020 | 2873 | 0.330 |
Why?
|
Fluorescent Dyes | 3 | 2015 | 1913 | 0.320 |
Why?
|
Mitochondrial Membranes | 4 | 2011 | 172 | 0.320 |
Why?
|
Cell Membrane | 2 | 2020 | 3682 | 0.320 |
Why?
|
Enzymes | 1 | 2010 | 261 | 0.320 |
Why?
|
Chromosomes, Human | 2 | 2011 | 442 | 0.310 |
Why?
|
Mice | 33 | 2024 | 81208 | 0.310 |
Why?
|
MAP Kinase Kinase Kinases | 3 | 2016 | 256 | 0.310 |
Why?
|
Cells | 1 | 2009 | 164 | 0.310 |
Why?
|
Molecular Motor Proteins | 2 | 2006 | 105 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 3 | 2022 | 3763 | 0.300 |
Why?
|
Fuzzy Logic | 4 | 2012 | 57 | 0.300 |
Why?
|
Antibodies | 3 | 2019 | 2421 | 0.300 |
Why?
|
Research Personnel | 1 | 2012 | 582 | 0.300 |
Why?
|
Information Dissemination | 1 | 2016 | 1131 | 0.290 |
Why?
|
Pyrimidinones | 2 | 2020 | 384 | 0.290 |
Why?
|
Cytokines | 9 | 2022 | 7343 | 0.290 |
Why?
|
Mammals | 3 | 2023 | 1131 | 0.290 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1846 | 0.290 |
Why?
|
DNA Damage | 8 | 2023 | 2442 | 0.280 |
Why?
|
Stress, Physiological | 1 | 2014 | 1398 | 0.280 |
Why?
|
Luminescent Proteins | 4 | 2008 | 835 | 0.280 |
Why?
|
Yeasts | 4 | 2003 | 279 | 0.280 |
Why?
|
Biological Products | 1 | 2016 | 916 | 0.280 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1374 | 0.280 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 590 | 0.270 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1147 | 0.270 |
Why?
|
Cytosol | 4 | 2018 | 887 | 0.270 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2006 | 180 | 0.260 |
Why?
|
HEK293 Cells | 6 | 2020 | 4264 | 0.260 |
Why?
|
Autocrine Communication | 2 | 2006 | 169 | 0.260 |
Why?
|
Gene Regulatory Networks | 4 | 2021 | 1741 | 0.260 |
Why?
|
Drug Industry | 1 | 2012 | 789 | 0.260 |
Why?
|
Gene Expression Regulation, Fungal | 4 | 2009 | 499 | 0.260 |
Why?
|
Inhibitory Concentration 50 | 2 | 2017 | 465 | 0.260 |
Why?
|
Reproducibility of Results | 15 | 2023 | 20080 | 0.260 |
Why?
|
Pyrazoles | 4 | 2020 | 1999 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.260 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2021 | 224 | 0.260 |
Why?
|
Pandemics | 5 | 2021 | 8624 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.250 |
Why?
|
Algorithms | 18 | 2024 | 13981 | 0.250 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6315 | 0.250 |
Why?
|
Phosphotransferases | 2 | 2021 | 303 | 0.250 |
Why?
|
Ubiquitination | 3 | 2022 | 1008 | 0.250 |
Why?
|
Bayes Theorem | 2 | 2013 | 2326 | 0.250 |
Why?
|
Biological Transport | 3 | 2024 | 2086 | 0.240 |
Why?
|
Protein Conformation | 8 | 2024 | 3969 | 0.240 |
Why?
|
Amino Acid Transport System ASC | 1 | 2024 | 16 | 0.240 |
Why?
|
Cysteine | 2 | 2020 | 895 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 5 | 2020 | 2418 | 0.240 |
Why?
|
Phosphoproteins | 8 | 2021 | 2440 | 0.240 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2020 | 2058 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2299 | 0.230 |
Why?
|
Amino Acid Transport Systems | 1 | 2024 | 35 | 0.230 |
Why?
|
Genes | 4 | 1989 | 1845 | 0.230 |
Why?
|
Pharmaceutical Preparations | 2 | 2011 | 1091 | 0.230 |
Why?
|
Receptor, erbB-3 | 2 | 2017 | 143 | 0.230 |
Why?
|
Chromatids | 2 | 2001 | 63 | 0.220 |
Why?
|
Flow Cytometry | 6 | 2019 | 5870 | 0.220 |
Why?
|
Diagnostic Imaging | 3 | 2023 | 3527 | 0.220 |
Why?
|
Anaphase | 5 | 2013 | 116 | 0.220 |
Why?
|
Information Storage and Retrieval | 3 | 2017 | 822 | 0.220 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2024 | 293 | 0.220 |
Why?
|
Genomic Instability | 3 | 2021 | 704 | 0.220 |
Why?
|
Protein Binding | 15 | 2021 | 9335 | 0.220 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1664 | 0.220 |
Why?
|
Immunoconjugates | 2 | 2024 | 949 | 0.210 |
Why?
|
Protein Interaction Mapping | 4 | 2017 | 617 | 0.210 |
Why?
|
Ketones | 1 | 2024 | 183 | 0.210 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6853 | 0.210 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 3 | 2007 | 169 | 0.210 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 687 | 0.210 |
Why?
|
Receptor, erbB-2 | 4 | 2020 | 2554 | 0.210 |
Why?
|
Furans | 1 | 2024 | 199 | 0.210 |
Why?
|
Endopeptidases | 2 | 2022 | 772 | 0.210 |
Why?
|
Genes, Fungal | 3 | 1995 | 439 | 0.210 |
Why?
|
Databases, Factual | 6 | 2023 | 8035 | 0.210 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2023 | 124 | 0.210 |
Why?
|
Imaging, Three-Dimensional | 5 | 2011 | 4048 | 0.210 |
Why?
|
Molecular Sequence Data | 17 | 2009 | 17624 | 0.210 |
Why?
|
Macromolecular Substances | 7 | 2004 | 1433 | 0.200 |
Why?
|
Amino Acid Sequence | 17 | 2020 | 13451 | 0.200 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8986 | 0.200 |
Why?
|
Tubulin Modulators | 3 | 2011 | 107 | 0.200 |
Why?
|
Enzyme Inhibitors | 5 | 2017 | 3726 | 0.200 |
Why?
|
Linear Models | 3 | 2019 | 5877 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 3 | 2022 | 6544 | 0.200 |
Why?
|
Gene Deletion | 3 | 2008 | 2668 | 0.200 |
Why?
|
Rhabdoid Tumor | 1 | 2024 | 210 | 0.200 |
Why?
|
src Homology Domains | 3 | 2021 | 361 | 0.200 |
Why?
|
Thiolester Hydrolases | 1 | 2022 | 85 | 0.200 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 216 | 0.190 |
Why?
|
Circadian Clocks | 1 | 2024 | 163 | 0.190 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2013 | 88 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 1407 | 0.190 |
Why?
|
Cells, Cultured | 10 | 2019 | 18957 | 0.190 |
Why?
|
Liposarcoma | 1 | 2024 | 283 | 0.190 |
Why?
|
NF-kappa B | 3 | 2018 | 2488 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 4550 | 0.190 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2696 | 0.190 |
Why?
|
Indicators and Reagents | 1 | 2002 | 461 | 0.190 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2895 | 0.180 |
Why?
|
Receptor, Insulin | 2 | 2019 | 836 | 0.180 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2012 | 59 | 0.180 |
Why?
|
Glutarates | 1 | 2022 | 244 | 0.180 |
Why?
|
Mitochondrial Proteins | 2 | 2022 | 979 | 0.180 |
Why?
|
Decontamination | 1 | 2021 | 72 | 0.180 |
Why?
|
Ligands | 4 | 2022 | 3276 | 0.180 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13262 | 0.180 |
Why?
|
Models, Statistical | 3 | 2022 | 5075 | 0.180 |
Why?
|
Models, Molecular | 5 | 2024 | 5434 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9276 | 0.180 |
Why?
|
Mice, Nude | 5 | 2019 | 3607 | 0.180 |
Why?
|
Serine | 1 | 2024 | 830 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1728 | 0.180 |
Why?
|
Knowledge Bases | 1 | 2021 | 98 | 0.180 |
Why?
|
Immunotherapy | 6 | 2023 | 4642 | 0.180 |
Why?
|
Nociceptors | 1 | 2024 | 457 | 0.180 |
Why?
|
Protein Transport | 3 | 2018 | 1964 | 0.180 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2020 | 59 | 0.180 |
Why?
|
Phenotype | 12 | 2022 | 16546 | 0.180 |
Why?
|
Protein Folding | 1 | 2024 | 867 | 0.180 |
Why?
|
Molecular Structure | 6 | 2020 | 1895 | 0.180 |
Why?
|
Quinazolines | 3 | 2011 | 1363 | 0.170 |
Why?
|
Sterilization | 1 | 2021 | 130 | 0.170 |
Why?
|
Leiomyosarcoma | 1 | 2024 | 424 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2020 | 183 | 0.170 |
Why?
|
Tumor Cells, Cultured | 7 | 2021 | 6131 | 0.170 |
Why?
|
Nootropic Agents | 1 | 2021 | 157 | 0.170 |
Why?
|
Transcription Factor CHOP | 1 | 2019 | 68 | 0.170 |
Why?
|
Cystadenoma, Serous | 1 | 2020 | 100 | 0.170 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1204 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 112 | 0.170 |
Why?
|
Karyotyping | 3 | 2014 | 1171 | 0.170 |
Why?
|
Cell Movement | 3 | 2019 | 5206 | 0.170 |
Why?
|
Sarcoma, Synovial | 1 | 2021 | 151 | 0.170 |
Why?
|
Models, Chemical | 1 | 2021 | 614 | 0.170 |
Why?
|
Cell Line, Transformed | 2 | 2011 | 869 | 0.170 |
Why?
|
Receptors, Somatomedin | 1 | 2019 | 56 | 0.170 |
Why?
|
Structure-Activity Relationship | 5 | 2020 | 3084 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 5 | 2008 | 727 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 362 | 0.160 |
Why?
|
Serotonin | 1 | 2024 | 1040 | 0.160 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.160 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2022 | 929 | 0.160 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2019 | 22 | 0.160 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 287 | 0.160 |
Why?
|
Macrophages | 7 | 2024 | 5745 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 454 | 0.160 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2803 | 0.160 |
Why?
|
Acrylamide | 1 | 2019 | 59 | 0.160 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2019 | 92 | 0.160 |
Why?
|
Pyrimidines | 4 | 2021 | 3016 | 0.160 |
Why?
|
Cerebellar Neoplasms | 1 | 2024 | 587 | 0.160 |
Why?
|
Acclimatization | 1 | 2019 | 112 | 0.160 |
Why?
|
Drugs, Investigational | 1 | 2021 | 214 | 0.160 |
Why?
|
Masks | 1 | 2021 | 209 | 0.160 |
Why?
|
Green Fluorescent Proteins | 5 | 2011 | 2057 | 0.160 |
Why?
|
Female | 39 | 2024 | 391270 | 0.160 |
Why?
|
Immunity | 2 | 2023 | 998 | 0.150 |
Why?
|
Ascites | 1 | 2020 | 338 | 0.150 |
Why?
|
Frontotemporal Dementia | 1 | 2021 | 246 | 0.150 |
Why?
|
Cataloging | 1 | 2017 | 9 | 0.150 |
Why?
|
Stem Cell Niche | 1 | 2021 | 346 | 0.150 |
Why?
|
Inflammation | 5 | 2024 | 10756 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3775 | 0.150 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 967 | 0.150 |
Why?
|
Extracellular Space | 1 | 2020 | 564 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1714 | 0.150 |
Why?
|
RNA Interference | 5 | 2013 | 2846 | 0.150 |
Why?
|
Transcription, Genetic | 8 | 2020 | 7593 | 0.150 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 828 | 0.150 |
Why?
|
Protein Processing, Post-Translational | 3 | 2012 | 1974 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 330 | 0.150 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8547 | 0.150 |
Why?
|
Sirtuin 3 | 1 | 2018 | 68 | 0.150 |
Why?
|
Meiosis | 2 | 2011 | 328 | 0.150 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 479 | 0.140 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 331 | 0.140 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 732 | 0.140 |
Why?
|
Phosphotyrosine | 2 | 2021 | 456 | 0.140 |
Why?
|
Uncertainty | 1 | 2022 | 754 | 0.140 |
Why?
|
src-Family Kinases | 1 | 2020 | 535 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 789 | 0.140 |
Why?
|
Tumor Necrosis Factors | 2 | 2023 | 106 | 0.140 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1885 | 0.140 |
Why?
|
Feedback, Physiological | 3 | 2009 | 476 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 798 | 0.140 |
Why?
|
Time Factors | 10 | 2017 | 40165 | 0.140 |
Why?
|
Drug Interactions | 2 | 2020 | 1428 | 0.140 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 141 | 0.140 |
Why?
|
Permeability | 2 | 2009 | 719 | 0.140 |
Why?
|
Anilides | 1 | 2020 | 409 | 0.140 |
Why?
|
Myeloid Cells | 1 | 2021 | 820 | 0.140 |
Why?
|
Cell Nucleus | 2 | 2022 | 2907 | 0.140 |
Why?
|
ras Proteins | 2 | 2020 | 1052 | 0.140 |
Why?
|
Recombination, Genetic | 1 | 2021 | 1526 | 0.140 |
Why?
|
Repressor Proteins | 6 | 2021 | 2981 | 0.140 |
Why?
|
Neoplasm Transplantation | 2 | 2017 | 2014 | 0.140 |
Why?
|
Receptor, IGF Type 1 | 2 | 2019 | 380 | 0.140 |
Why?
|
Amides | 1 | 2019 | 448 | 0.130 |
Why?
|
Hot Temperature | 4 | 1991 | 1435 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2020 | 755 | 0.130 |
Why?
|
Brain Edema | 1 | 2020 | 603 | 0.130 |
Why?
|
RNA | 3 | 2024 | 2722 | 0.130 |
Why?
|
Base Sequence | 11 | 2016 | 12446 | 0.130 |
Why?
|
Ubiquitins | 1 | 1997 | 370 | 0.130 |
Why?
|
F-Box Proteins | 1 | 1997 | 202 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5251 | 0.130 |
Why?
|
Uveal Neoplasms | 1 | 2019 | 341 | 0.130 |
Why?
|
Nocodazole | 3 | 2011 | 95 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 370 | 0.130 |
Why?
|
Cricetulus | 1 | 2017 | 815 | 0.130 |
Why?
|
Chromosome Aberrations | 3 | 2014 | 1764 | 0.130 |
Why?
|
Craniopharyngioma | 1 | 2018 | 277 | 0.130 |
Why?
|
Insulin | 5 | 2024 | 6597 | 0.130 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2015 | 46 | 0.130 |
Why?
|
Stromal Cells | 2 | 2018 | 1326 | 0.130 |
Why?
|
Receptors, Death Domain | 1 | 2015 | 31 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2024 | 916 | 0.130 |
Why?
|
Transcription Factors | 6 | 2021 | 12103 | 0.130 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10181 | 0.130 |
Why?
|
Nucleotides | 1 | 2018 | 450 | 0.130 |
Why?
|
Pattern Recognition, Automated | 1 | 2021 | 994 | 0.120 |
Why?
|
Mitochondria | 4 | 2013 | 3600 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2021 | 615 | 0.120 |
Why?
|
CHO Cells | 1 | 2017 | 1389 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2014 | 1693 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1139 | 0.120 |
Why?
|
Lab-On-A-Chip Devices | 3 | 2008 | 432 | 0.120 |
Why?
|
Centrosome | 2 | 2008 | 207 | 0.120 |
Why?
|
Cisplatin | 1 | 2020 | 1644 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 90 | 0.120 |
Why?
|
HT29 Cells | 5 | 2005 | 190 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 597 | 0.120 |
Why?
|
Genomics | 7 | 2024 | 5794 | 0.120 |
Why?
|
Thalidomide | 1 | 2019 | 884 | 0.120 |
Why?
|
S Phase | 2 | 2013 | 422 | 0.120 |
Why?
|
Drug Delivery Systems | 3 | 2017 | 2221 | 0.120 |
Why?
|
Coloring Agents | 1 | 2016 | 562 | 0.120 |
Why?
|
Neuroprotective Agents | 1 | 2021 | 961 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1520 | 0.110 |
Why?
|
Epithelial Cells | 1 | 2006 | 3663 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2021 | 1738 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 5 | 2008 | 3735 | 0.110 |
Why?
|
Internet | 3 | 2021 | 3078 | 0.110 |
Why?
|
Prescription Drugs | 1 | 2021 | 630 | 0.110 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 71 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2014 | 215 | 0.110 |
Why?
|
Protein Structure, Tertiary | 4 | 2014 | 3800 | 0.110 |
Why?
|
Dexamethasone | 1 | 2020 | 1927 | 0.110 |
Why?
|
G2 Phase | 2 | 2007 | 133 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3315 | 0.110 |
Why?
|
Recombinant Proteins | 4 | 2011 | 6538 | 0.110 |
Why?
|
Observer Variation | 1 | 2019 | 2601 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2021 | 951 | 0.110 |
Why?
|
Chromatin | 3 | 2001 | 2938 | 0.110 |
Why?
|
Lymphoma | 1 | 2022 | 1898 | 0.110 |
Why?
|
Cloning, Molecular | 5 | 1999 | 4169 | 0.110 |
Why?
|
Neuregulin-1 | 1 | 2013 | 135 | 0.110 |
Why?
|
Sarcoma | 1 | 2024 | 1786 | 0.100 |
Why?
|
Retinal Diseases | 1 | 2019 | 702 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1596 | 0.100 |
Why?
|
Pyrroles | 1 | 2019 | 1137 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1189 | 0.100 |
Why?
|
Language | 2 | 2022 | 1533 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2020 | 11481 | 0.100 |
Why?
|
Maturation-Promoting Factor | 1 | 1992 | 26 | 0.100 |
Why?
|
bcl-2-Associated X Protein | 1 | 2013 | 282 | 0.100 |
Why?
|
Membrane Proteins | 3 | 2018 | 7850 | 0.100 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 444 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2014 | 956 | 0.100 |
Why?
|
Potoroidae | 1 | 2011 | 7 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4351 | 0.100 |
Why?
|
Cell Count | 1 | 2016 | 1835 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1182 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2828 | 0.100 |
Why?
|
Cyclin B | 1 | 2011 | 104 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3610 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2013 | 4490 | 0.100 |
Why?
|
Molecular Probes | 1 | 2013 | 313 | 0.100 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4319 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2414 | 0.100 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11903 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 3340 | 0.090 |
Why?
|
Dimerization | 4 | 2014 | 891 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2011 | 1881 | 0.090 |
Why?
|
Chromosomes, Mammalian | 1 | 2011 | 146 | 0.090 |
Why?
|
STAT Transcription Factors | 2 | 2023 | 188 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2014 | 646 | 0.090 |
Why?
|
Clone Cells | 1 | 2014 | 1660 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1612 | 0.090 |
Why?
|
Phylogeny | 3 | 2021 | 2775 | 0.090 |
Why?
|
Peptides | 2 | 2020 | 4354 | 0.090 |
Why?
|
Protein Subunits | 4 | 2007 | 943 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1677 | 0.090 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 428 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1636 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2825 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1463 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1998 | 0.090 |
Why?
|
Calibration | 1 | 2013 | 816 | 0.090 |
Why?
|
Medical Oncology | 1 | 2022 | 2313 | 0.090 |
Why?
|
Gene Dosage | 1 | 2014 | 1218 | 0.090 |
Why?
|
Binding Sites | 3 | 2012 | 6048 | 0.090 |
Why?
|
Transcriptional Activation | 3 | 2013 | 1755 | 0.080 |
Why?
|
Adenosine Triphosphate | 2 | 2013 | 1993 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1313 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 730 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1403 | 0.080 |
Why?
|
Apoptosomes | 1 | 2008 | 4 | 0.080 |
Why?
|
Sequence Alignment | 3 | 2022 | 2176 | 0.080 |
Why?
|
Hair | 1 | 2013 | 497 | 0.080 |
Why?
|
Crystallography, X-Ray | 5 | 2016 | 1982 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.080 |
Why?
|
Centromere Protein B | 1 | 2008 | 3 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5066 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2015 | 1313 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2011 | 1529 | 0.080 |
Why?
|
Paraffin Embedding | 2 | 2019 | 302 | 0.080 |
Why?
|
Caspase 9 | 1 | 2008 | 185 | 0.080 |
Why?
|
Glutamine | 2 | 2024 | 576 | 0.080 |
Why?
|
Substrate Specificity | 2 | 2019 | 1792 | 0.080 |
Why?
|
Antibodies, Neutralizing | 2 | 2020 | 1933 | 0.080 |
Why?
|
Paclitaxel | 3 | 2011 | 1736 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 854 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 1997 | 1889 | 0.080 |
Why?
|
Formaldehyde | 2 | 2019 | 358 | 0.080 |
Why?
|
HCT116 Cells | 2 | 2019 | 402 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18137 | 0.080 |
Why?
|
Biophysical Phenomena | 2 | 2020 | 320 | 0.070 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3420 | 0.070 |
Why?
|
Cell Communication | 3 | 2017 | 1653 | 0.070 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1257 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 788 | 0.070 |
Why?
|
Biomedical Research | 2 | 2016 | 3426 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12531 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2004 | 1343 | 0.070 |
Why?
|
Plant Viruses | 1 | 1986 | 40 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 886 | 0.070 |
Why?
|
Nondisjunction, Genetic | 1 | 2006 | 24 | 0.070 |
Why?
|
Mathematics | 1 | 2008 | 707 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3568 | 0.070 |
Why?
|
Cells, Immobilized | 1 | 2006 | 35 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2021 | 14372 | 0.070 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 419 | 0.070 |
Why?
|
DNA Primers | 2 | 2005 | 2819 | 0.070 |
Why?
|
Drug Therapy | 1 | 2009 | 504 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2023 | 80372 | 0.070 |
Why?
|
Metaphase | 1 | 2006 | 144 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 3052 | 0.070 |
Why?
|
Stimulation, Chemical | 1 | 2006 | 306 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1928 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2105 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2013 | 818 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2018 | 1246 | 0.060 |
Why?
|
Receptor Cross-Talk | 1 | 2006 | 116 | 0.060 |
Why?
|
beta Catenin | 1 | 2011 | 1043 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2009 | 14660 | 0.060 |
Why?
|
RNA Viruses | 1 | 1986 | 110 | 0.060 |
Why?
|
Molecular Biology | 2 | 2010 | 580 | 0.060 |
Why?
|
Lamin Type A | 1 | 2006 | 187 | 0.060 |
Why?
|
Drug Approval | 1 | 2012 | 816 | 0.060 |
Why?
|
Interleukin-1 | 2 | 2006 | 1249 | 0.060 |
Why?
|
United States | 5 | 2021 | 72461 | 0.060 |
Why?
|
Plasma | 1 | 2008 | 584 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2009 | 2753 | 0.060 |
Why?
|
Clathrin | 1 | 1986 | 257 | 0.060 |
Why?
|
DNA | 3 | 2002 | 7233 | 0.060 |
Why?
|
Drug Design | 2 | 2021 | 1061 | 0.060 |
Why?
|
Membrane Potentials | 1 | 2008 | 1095 | 0.060 |
Why?
|
Organ Specificity | 1 | 2009 | 1955 | 0.060 |
Why?
|
Hormones | 1 | 2008 | 867 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1987 | 397 | 0.060 |
Why?
|
Liver | 2 | 2011 | 7509 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 998 | 0.060 |
Why?
|
Protein Structure, Secondary | 2 | 2024 | 1229 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1088 | 0.060 |
Why?
|
Zymosan | 1 | 2024 | 136 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5785 | 0.060 |
Why?
|
Crosses, Genetic | 1 | 2005 | 751 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2023 | 3157 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1500 | 0.060 |
Why?
|
Autoantigens | 1 | 2008 | 877 | 0.060 |
Why?
|
Environment | 1 | 2010 | 1118 | 0.060 |
Why?
|
Benzamides | 3 | 2018 | 1369 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1055 | 0.060 |
Why?
|
Macaca mulatta | 2 | 2020 | 2316 | 0.060 |
Why?
|
Growth Substances | 1 | 2006 | 768 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2475 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 74 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2006 | 863 | 0.050 |
Why?
|
Microfluidics | 1 | 2008 | 652 | 0.050 |
Why?
|
ARNTL Transcription Factors | 1 | 2024 | 94 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1173 | 0.050 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2005 | 557 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 2 | 2002 | 1304 | 0.050 |
Why?
|
Claudins | 1 | 2024 | 115 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2526 | 0.050 |
Why?
|
Blotting, Western | 2 | 2014 | 5039 | 0.050 |
Why?
|
Neurons | 2 | 2021 | 9426 | 0.050 |
Why?
|
Prognosis | 5 | 2022 | 29658 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4902 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22023 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2024 | 257 | 0.050 |
Why?
|
Blastocyst | 1 | 2005 | 433 | 0.050 |
Why?
|
Neuroimmunomodulation | 1 | 2024 | 177 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2019 | 736 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 772 | 0.050 |
Why?
|
Multiprotein Complexes | 4 | 2012 | 1120 | 0.050 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 251 | 0.050 |
Why?
|
Piperidines | 2 | 2021 | 1650 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2117 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3380 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 250 | 0.050 |
Why?
|
Mutagenesis | 3 | 1999 | 1234 | 0.050 |
Why?
|
Species Specificity | 1 | 2006 | 2418 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 436 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4417 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 412 | 0.050 |
Why?
|
Biflavonoids | 1 | 2021 | 11 | 0.050 |
Why?
|
Genetic Variation | 2 | 2014 | 6551 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1744 | 0.050 |
Why?
|
DNA Repeat Expansion | 1 | 2021 | 72 | 0.050 |
Why?
|
Spheroids, Cellular | 1 | 2023 | 329 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 376 | 0.050 |
Why?
|
Poly A | 1 | 2021 | 181 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 50 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2021 | 45 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2575 | 0.050 |
Why?
|
Phospholipase C gamma | 1 | 2021 | 130 | 0.050 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2020 | 81 | 0.050 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 814 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 271 | 0.050 |
Why?
|
Gene Library | 2 | 2017 | 1060 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 129 | 0.040 |
Why?
|
Odds Ratio | 1 | 2013 | 9716 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2005 | 0.040 |
Why?
|
Skin | 2 | 2024 | 4466 | 0.040 |
Why?
|
Butadienes | 2 | 2010 | 107 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2020 | 107 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 65017 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2024 | 580 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1649 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4353 | 0.040 |
Why?
|
G1 Phase | 2 | 1999 | 403 | 0.040 |
Why?
|
Trans-Activators | 1 | 1989 | 2860 | 0.040 |
Why?
|
Phase Transition | 1 | 2020 | 71 | 0.040 |
Why?
|
Stem Cells | 1 | 2013 | 3523 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 295 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 362 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 118 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2013 | 6068 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2023 | 5496 | 0.040 |
Why?
|
Catalysis | 1 | 2021 | 775 | 0.040 |
Why?
|
Pheromones | 1 | 1999 | 93 | 0.040 |
Why?
|
Peptide Mapping | 1 | 1999 | 262 | 0.040 |
Why?
|
DNA Replication | 1 | 2006 | 1412 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41335 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2020 | 179 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1871 | 0.040 |
Why?
|
Wnt Proteins | 2 | 2014 | 719 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2020 | 241 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 232 | 0.040 |
Why?
|
Disinfection | 1 | 2021 | 209 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2002 | 778 | 0.040 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2005 | 806 | 0.040 |
Why?
|
Tissue Fixation | 1 | 2019 | 241 | 0.040 |
Why?
|
Complement Activation | 1 | 2020 | 446 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 603 | 0.040 |
Why?
|
Azaserine | 1 | 2018 | 8 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1992 | 1055 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 2005 | 2558 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2020 | 267 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2362 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12922 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
Elasticity | 1 | 2000 | 652 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 302 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4573 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2022 | 765 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 1991 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 748 | 0.040 |
Why?
|
Mitogens | 1 | 2018 | 230 | 0.040 |
Why?
|
Guanosine Diphosphate | 1 | 1997 | 80 | 0.040 |
Why?
|
Phototherapy | 1 | 2021 | 368 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 834 | 0.040 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1999 | 330 | 0.040 |
Why?
|
Information Theory | 1 | 2017 | 49 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 568 | 0.040 |
Why?
|
Molecular Weight | 2 | 1990 | 2186 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 383 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2020 | 412 | 0.040 |
Why?
|
Platelet Activation | 1 | 2020 | 660 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 2016 | 173 | 0.030 |
Why?
|
Guanosine Triphosphate | 1 | 1997 | 316 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 729 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2018 | 435 | 0.030 |
Why?
|
Ligases | 1 | 1997 | 332 | 0.030 |
Why?
|
Up-Regulation | 2 | 2018 | 4122 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 705 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 718 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2209 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1173 | 0.030 |
Why?
|
DNA Footprinting | 1 | 1995 | 97 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2020 | 604 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 559 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 895 | 0.030 |
Why?
|
Endocytosis | 1 | 2020 | 959 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
Temperature | 3 | 2007 | 2221 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1085 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1617 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 410 | 0.030 |
Why?
|
Nitriles | 2 | 2010 | 956 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1617 | 0.030 |
Why?
|
Image Enhancement | 1 | 2005 | 2881 | 0.030 |
Why?
|
Selection, Genetic | 1 | 1999 | 869 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1997 | 685 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2222 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2536 | 0.030 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
National Health Programs | 1 | 2017 | 441 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39261 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1557 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1997 | 899 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1832 | 0.030 |
Why?
|
Least-Squares Analysis | 2 | 2005 | 369 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 791 | 0.030 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2016 | 259 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 19 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 965 | 0.030 |
Why?
|
Male | 9 | 2024 | 359744 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1354 | 0.030 |
Why?
|
Spodoptera | 2 | 2005 | 141 | 0.030 |
Why?
|
Breast | 1 | 2022 | 1963 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11071 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1804 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 792 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 4713 | 0.030 |
Why?
|
Ion Channels | 1 | 2017 | 1043 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2432 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2571 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 317 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3529 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2013 | 532 | 0.020 |
Why?
|
Lung | 2 | 2020 | 9994 | 0.020 |
Why?
|
Immobilized Proteins | 1 | 2011 | 25 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2013 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4107 | 0.020 |
Why?
|
Time-Lapse Imaging | 1 | 2012 | 193 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 911 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3767 | 0.020 |
Why?
|
Movement | 1 | 1998 | 1474 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 1992 | 213 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3322 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1858 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2013 | 428 | 0.020 |
Why?
|
Computers, Molecular | 1 | 2010 | 14 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 453 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8555 | 0.020 |
Why?
|
Child | 3 | 2024 | 79806 | 0.020 |
Why?
|
Diphenylamine | 1 | 2010 | 49 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 283 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58995 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 877 | 0.020 |
Why?
|
Logic | 1 | 2010 | 42 | 0.020 |
Why?
|
U937 Cells | 1 | 2010 | 262 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 101 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2011 | 389 | 0.020 |
Why?
|
Clarithromycin | 1 | 2010 | 85 | 0.020 |
Why?
|
Culture Media | 1 | 2012 | 900 | 0.020 |
Why?
|
Interleukins | 1 | 2014 | 785 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 220352 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 716 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2525 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 489 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3143 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 719 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3839 | 0.020 |
Why?
|
Rats | 3 | 2011 | 23711 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2011 | 877 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3616 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1342 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4000 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169152 | 0.020 |
Why?
|
Feedback | 1 | 1992 | 791 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2009 | 825 | 0.020 |
Why?
|
Fluoroquinolones | 1 | 2010 | 308 | 0.020 |
Why?
|
Microspheres | 1 | 2011 | 787 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8482 | 0.020 |
Why?
|
Tyrosine | 1 | 1992 | 1438 | 0.020 |
Why?
|
Antimitotic Agents | 1 | 2007 | 29 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12960 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2506 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1986 | 299 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3928 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2532 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12808 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2007 | 198 | 0.020 |
Why?
|
Oocytes | 1 | 2011 | 1165 | 0.020 |
Why?
|
Cell Extracts | 1 | 2006 | 135 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2192 | 0.020 |
Why?
|
Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.020 |
Why?
|
Education | 1 | 2008 | 534 | 0.020 |
Why?
|
Crystallization | 1 | 1986 | 533 | 0.020 |
Why?
|
Genes, ras | 1 | 2007 | 655 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5761 | 0.010 |
Why?
|
Brain | 2 | 2021 | 26951 | 0.010 |
Why?
|
Multigene Family | 1 | 2007 | 1077 | 0.010 |
Why?
|
Capsid | 1 | 1986 | 434 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.010 |
Why?
|
Cricetinae | 1 | 1987 | 2427 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2016 | 3539 | 0.010 |
Why?
|
Immunoassay | 1 | 2006 | 746 | 0.010 |
Why?
|
Buffers | 1 | 2002 | 144 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15840 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 257 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 981 | 0.010 |
Why?
|
Plasmids | 1 | 1987 | 2275 | 0.010 |
Why?
|
Surface Properties | 1 | 2005 | 1161 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5130 | 0.010 |
Why?
|
Solutions | 1 | 2002 | 419 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1986 | 2502 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3441 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 1991 | 1699 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2002 | 660 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2802 | 0.010 |
Why?
|
Electrons | 1 | 2002 | 264 | 0.010 |
Why?
|
Pyridines | 1 | 2012 | 2879 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29749 | 0.010 |
Why?
|
Biological Assay | 1 | 2003 | 630 | 0.010 |
Why?
|
Micrococcal Nuclease | 1 | 1999 | 36 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5781 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9530 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11152 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2006 | 1726 | 0.010 |
Why?
|
Galactose | 1 | 1999 | 297 | 0.010 |
Why?
|
RNA, Viral | 1 | 1986 | 2838 | 0.010 |
Why?
|
Peptide Library | 1 | 1999 | 347 | 0.010 |
Why?
|
Hydrolysis | 1 | 1997 | 665 | 0.010 |
Why?
|
Lipoproteins | 1 | 1999 | 882 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
Tubulin | 1 | 1997 | 692 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12159 | 0.010 |
Why?
|
Polymers | 1 | 1997 | 1621 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 2592 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9185 | 0.000 |
Why?
|
Adult | 1 | 2020 | 219994 | 0.000 |
Why?
|